A round of Series C financing brought in $25 million for Cleveland-based medical device startup SPR Therapeutics. The proceeds will be used for commercializing the company's SPRINT Peripheral Nerve Stimulation system for chronic and acute pain, as well as to support additional studies exploring other indications for the technology.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.